Saturday, 3 August 2019

Catalyst Biosciences Reports Second Quarter 2019 Operating & Financial Results and Provides a Corporate Update - Yahoo Finance

Catalyst Biosciences Reports Second Quarter 2019 Operating & Financial Results and Provides a Corporate Update  Yahoo Finance

Phase 2 trial of subcutaneously administered MarzAA met primary endpoint of reduction in annualized bleed rate demonstrating safety and clinical efficacy, with ...

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)